Enhanced tumor microenvironment immune-activating drug candidate  for solid tumors

OGB23501

Pipeline Code

OGB23501

Modality

Large-molecule (Biologics)

Program Target

PD-1 x VEGF x CTLA4 (tri-specific)

Molecular size

120 kDa

Disease Indication

Solid Tumors

Development Stage

Lead Discovery (Lead candidate ready in 4Q 2023)